Research Scientist-R&D (Synthesis) presso PCC-India-DIGWAL-Unit-III - Production (Bottling Plant)
PCC-India-DIGWAL-Unit-III - Production (Bottling Plant) · Navi Mumbai, India · Onsite
- Professional
- Ufficio in Navi Mumbai
Route Design & Development:
- Develop novel and non-infringing synthetic routes for APIs and key intermediates.
- Evaluate literature and patent landscape for synthetic feasibility and freedom to operate.
Process Optimization:
- Conduct lab-scale synthesis and optimize reaction conditions for yield, purity, and scalability.
- Support process development and scale-up activities from lab to kilo-lab and plant level.
Analytical & Regulatory Support:
- Coordinate with Analytical R&D for impurity profiling and characterization of intermediates.
- Support preparation of technical data for DMF, ANDA, and regulatory submissions.
Technology Transfer:
- He will prepare process development report and transfer to technology to manufacturing site.
Safety & Compliance:
- Ensure all experiments follow EHS and GMP guidelines.
- Maintain accurate laboratory records, MSDS, and reaction logs.
Qualifications
MSc. Organic Chemistry or Ph.D. in Organic Chemistry will be added advantage
About Company
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited’s investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovators and generic companies worldwide.
Company
In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.
Equal employment opportunity
Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.
We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.
